The proteomic analysis of bovine embryos developed in vivo or in vitro reveals the contribution of the maternal environment to early embryo.
Blastocyst
Cattle
Development
Embryo
Mass spectrometry
Morula
Oviduct
Proteomics
Journal
BMC genomics
ISSN: 1471-2164
Titre abrégé: BMC Genomics
Pays: England
ID NLM: 100965258
Informations de publication
Date de publication:
19 Dec 2022
19 Dec 2022
Historique:
received:
26
09
2022
accepted:
08
12
2022
entrez:
19
12
2022
pubmed:
20
12
2022
medline:
22
12
2022
Statut:
epublish
Résumé
Despite many improvements with in vitro culture systems, the quality and developmental ability of mammalian embryos produced in vitro are still lower than their in vivo counterparts. Though previous studies have evidenced differences in gene expression between in vivo- and in vitro-derived bovine embryos, there is no comparison at the protein expression level. A total of 38 pools of grade-1 quality bovine embryos at the 4-6 cell, 8-12 cell, morula, compact morula, and blastocyst stages developed either in vivo or in vitro were analyzed by nano-liquid chromatography coupled with label-free quantitative mass spectrometry, allowing for the identification of 3,028 proteins. Multivariate analysis of quantified proteins showed a clear separation of embryo pools according to their in vivo or in vitro origin at all stages. Three clusters of differentially abundant proteins (DAPs) were evidenced according to embryo origin, including 463 proteins more abundant in vivo than in vitro across development and 314 and 222 proteins more abundant in vitro than in vivo before and after the morula stage, respectively. The functional analysis of proteins found more abundant in vivo showed an enrichment in carbohydrate metabolism and cytoplasmic cellular components. Proteins found more abundant in vitro before the morula stage were mostly localized in mitochondrial matrix and involved in ATP-dependent activity, while those overabundant after the morula stage were mostly localized in the ribonucleoprotein complex and involved in protein synthesis. Oviductin and other oviductal proteins, previously shown to interact with early embryos, were among the most overabundant proteins after in vivo development. The maternal environment led to higher degradation of mitochondrial proteins at early developmental stages, lower abundance of proteins involved in protein synthesis at the time of embryonic genome activation, and a global upregulation of carbohydrate metabolic pathways compared to in vitro production. Furthermore, embryos developed in vivo internalized large amounts of oviductin and other proteins probably originated in the oviduct as soon as the 4-6 cell stage. These data provide new insight into the molecular contribution of the mother to the developmental ability of early embryos and will help design better in vitro culture systems.
Sections du résumé
BACKGROUND
BACKGROUND
Despite many improvements with in vitro culture systems, the quality and developmental ability of mammalian embryos produced in vitro are still lower than their in vivo counterparts. Though previous studies have evidenced differences in gene expression between in vivo- and in vitro-derived bovine embryos, there is no comparison at the protein expression level.
RESULTS
RESULTS
A total of 38 pools of grade-1 quality bovine embryos at the 4-6 cell, 8-12 cell, morula, compact morula, and blastocyst stages developed either in vivo or in vitro were analyzed by nano-liquid chromatography coupled with label-free quantitative mass spectrometry, allowing for the identification of 3,028 proteins. Multivariate analysis of quantified proteins showed a clear separation of embryo pools according to their in vivo or in vitro origin at all stages. Three clusters of differentially abundant proteins (DAPs) were evidenced according to embryo origin, including 463 proteins more abundant in vivo than in vitro across development and 314 and 222 proteins more abundant in vitro than in vivo before and after the morula stage, respectively. The functional analysis of proteins found more abundant in vivo showed an enrichment in carbohydrate metabolism and cytoplasmic cellular components. Proteins found more abundant in vitro before the morula stage were mostly localized in mitochondrial matrix and involved in ATP-dependent activity, while those overabundant after the morula stage were mostly localized in the ribonucleoprotein complex and involved in protein synthesis. Oviductin and other oviductal proteins, previously shown to interact with early embryos, were among the most overabundant proteins after in vivo development.
CONCLUSIONS
CONCLUSIONS
The maternal environment led to higher degradation of mitochondrial proteins at early developmental stages, lower abundance of proteins involved in protein synthesis at the time of embryonic genome activation, and a global upregulation of carbohydrate metabolic pathways compared to in vitro production. Furthermore, embryos developed in vivo internalized large amounts of oviductin and other proteins probably originated in the oviduct as soon as the 4-6 cell stage. These data provide new insight into the molecular contribution of the mother to the developmental ability of early embryos and will help design better in vitro culture systems.
Identifiants
pubmed: 36536309
doi: 10.1186/s12864-022-09076-5
pii: 10.1186/s12864-022-09076-5
pmc: PMC9764490
doi:
Substances chimiques
Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
839Subventions
Organisme : Association Nationale de la Recherche et de la Technologie
ID : 2017/0684
Organisme : Association Nationale de la Recherche et de la Technologie
ID : 2017/0684
Organisme : Association Nationale de la Recherche et de la Technologie
ID : 2017/0684
Informations de copyright
© 2022. The Author(s).
Références
Biol Reprod. 2000 Apr;62(4):847-56
pubmed: 10727252
Hum Reprod Open. 2021 Aug 05;2021(3):hoab026
pubmed: 34377841
Mol Reprod Dev. 2002 Jul;62(3):320-7
pubmed: 12112595
Reproduction. 2017 Sep;154(3):153-168
pubmed: 28630101
Reprod Domest Anim. 2008 Oct;43 Suppl 4:44-50
pubmed: 18803756
J Reprod Fertil. 1972 May;29(2):307-11
pubmed: 5063359
Int J Mol Sci. 2021 Mar 26;22(7):
pubmed: 33810351
Nat Rev Genet. 2019 Apr;20(4):221-234
pubmed: 30573849
Mol Reprod Dev. 1998 Jun;50(2):139-45
pubmed: 9590529
Mol Reprod Dev. 2003 Apr;64(4):492-8
pubmed: 12589661
Theriogenology. 2010 Apr 1;73(6):777-85
pubmed: 19939442
Mol Reprod Dev. 1998 Dec;51(4):381-9
pubmed: 9820196
Theriogenology. 1998 Jan 1;49(1):83-102
pubmed: 10732123
Int J Dev Biol. 2010;54(8-9):1277-85
pubmed: 20712003
Reprod Fertil Dev. 2017 Mar;29(3):621-629
pubmed: 26462440
Anal Chem. 2002 Oct 15;74(20):5383-92
pubmed: 12403597
PLoS One. 2013 Aug 15;8(8):e67834
pubmed: 23967049
J Endocrinol. 2017 Jan;232(1):R1-R26
pubmed: 27875265
J Proteome Res. 2014 Oct 3;13(10):4363-76
pubmed: 25102770
BMC Bioinformatics. 2014 Aug 29;15:293
pubmed: 25176396
J Exp Zool. 1992 Aug 15;263(2):225-9
pubmed: 1500886
Reprod Domest Anim. 2008 Dec;43(6):720-9
pubmed: 18484958
Anim Reprod Sci. 2014 Sep;149(1-2):46-58
pubmed: 24975847
BMC Genomics. 2018 Jun 1;19(1):424
pubmed: 29859035
Int J Mol Sci. 2020 Jan 11;21(2):
pubmed: 31940782
Mol Reprod Dev. 2002 Feb;61(2):234-48
pubmed: 11803560
Theriogenology. 2011 Apr 1;75(6):1005-15
pubmed: 21196036
Biol Reprod. 1993 Jan;48(1):77-88
pubmed: 8418918
Front Physiol. 2022 May 11;13:899485
pubmed: 35634152
Mol Reprod Dev. 2007 Oct;74(10):1345-53
pubmed: 17342740
Reprod Fertil Dev. 2005;17(8):775-84
pubmed: 16476204
Mol Reprod Dev. 2009 Jan;76(1):38-47
pubmed: 18449896
Anim Reprod. 2020 Aug 04;17(3):e20200015
pubmed: 33029209
Reproduction. 2017 Apr;153(4):461-470
pubmed: 28104825
Biol Reprod. 1990 Aug;43(2):340-6
pubmed: 2198954
BMC Genomics. 2012 Mar 28;13:118
pubmed: 22452724
Front Cell Dev Biol. 2022 Mar 21;10:863700
pubmed: 35386205
Mol Cell Proteomics. 2005 Oct;4(10):1487-502
pubmed: 15979981
Biol Reprod. 1993 Jun;48(6):1274-83
pubmed: 8318581
Hum Reprod Update. 2010 Sep-Oct;16(5):488-509
pubmed: 20231166
Biol Reprod. 2002 Mar;66(3):589-95
pubmed: 11870062
Reprod Biomed Online. 2002 Mar-Apr;4(2):170-5
pubmed: 12470581
Mol Reprod Dev. 2008 Mar;75(3):496-503
pubmed: 17926343
J Dairy Sci. 2010 Mar;93(3):1022-9
pubmed: 20172222
Front Genet. 2022 Jan 14;12:780113
pubmed: 35096004
Mol Reprod Dev. 2001 Feb;58(2):186-95
pubmed: 11139231
J Anim Sci. 2019 May 30;97(6):2555-2568
pubmed: 30968113
Biol Reprod. 2012 Oct 25;87(4):100
pubmed: 22811576
Anal Chem. 2004 Jul 15;76(14):4193-201
pubmed: 15253663
Sci Rep. 2021 Jun 2;11(1):11618
pubmed: 34078963
Reprod Biol Endocrinol. 2017 Nov 25;15(1):91
pubmed: 29178958
Mol Hum Reprod. 2016 Feb;22(2):110-8
pubmed: 26646501
Anal Chem. 2003 Sep 1;75(17):4646-58
pubmed: 14632076
Animal. 2020 May;14(5):991-1004
pubmed: 31760966
Mol Reprod Dev. 2008 Jun;75(6):976-88
pubmed: 18357560
Mol Reprod Dev. 2002 Jan;61(1):57-66
pubmed: 11774376
Bioessays. 2002 Sep;24(9):845-9
pubmed: 12210521
Nat Commun. 2019 Apr 3;10(1):1523
pubmed: 30944313
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552
pubmed: 34723319
J Reprod Dev. 2020 Feb 14;66(1):35-39
pubmed: 31748448
Sci Rep. 2022 Mar 9;12(1):4135
pubmed: 35264682
Endocrinology. 2008 Mar;149(3):1268-76
pubmed: 18039777
Cell Res. 2002 Mar;12(1):69-78
pubmed: 11942413
J Anim Sci Biotechnol. 2017 Sep 1;8:69
pubmed: 28883914
BMC Genomics. 2017 Apr 5;18(1):280
pubmed: 28381255
Theriogenology. 1999 Sep;52(4):683-700
pubmed: 10734366
BMC Genomics. 2014 Sep 04;15:756
pubmed: 25185836
J Anim Sci Biotechnol. 2012 Nov 17;3(1):37
pubmed: 23157819
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19768-73
pubmed: 19064908